SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Venus Remedies informs about broad meeting

01 Feb 2020 Evaluate

Venus Remedies has informed that the meeting of the Board of Directors of the Company is scheduled on 12/02/2020 to consider and approve unaudited financial results for the quarter ended on 31st December, 2019 and any other item with the permission of Chair. Further, as already informed, the trading windorr would remain closed till 48 hours from the publication of financial results ior designated persons and their immediate relatives, in view of the aforesaid Board meeting.

The above information is a part of company’s filings submitted to BSE.

Venus Remedies Share Price

1735.30 70.65 (4.24%)
07-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1903.00
Dr. Reddys Labs. 1353.75
Cipla 1452.35
Zydus Lifesciences 1152.90
Lupin 2489.85
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: